Helen Bridge DPhil
Helen is a biologist and linguist who has always enjoyed both writing and interpreting data. After leaving her previous career as a university teacher and researcher in German literature, she completed a degree in life sciences with statistics, and became a medical writer in 2012. She worked in a CRO for 6 years before moving to AstraZeneca in March 2018. She has written a wide range of regulatory documents, with a particular focus on CTD clinical summaries and overviews, study reports, and protocols.